Alzheimer’s disease: The right drug, the right time
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
Posts tagged as
Steven DeKosky
MBI deputy director recognized for most-cited works
Dr. Steven DeKosky, M.D., was listed among the most influential authors in his field worldwide based on frequency of citations by peers.
Number of veterans with Alzheimer’s and other dementias on the rise
Retired Col. Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.
Examining the link between contact sports and neurological disease
Steven DeKosky, M.D., professor of neurology and deputy director of the McKnight Brain Institute, was recently featured in a story published by the American Academy of Neurology's Brain & Life magazine revisiting the paper he co-authored with Dr. Bennet Omalu about CTE.
Dr. Steven DeKosky discusses Alzheimer’s diagnostics
Bill Gates recently invested in a venture fund to improve diagnostic testing for Alzheimer's. Steven DeKosky, M.D., discusses the importance of an early diagnosis for patients and researchers.
MBI members’ commentary on NFL mortality study featured in JAMA issue
Drs. DeKosky, Jaffee and Bauer's JAMA editorial addresses long-term mortality in NFL football players.
